CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: mirex
Accession: CHEBI:34852
browse the term
Definition: A chlorocarbon that has formula C10Cl12.
Synonyms: exact_synonym: 1,1a,2,2,3,3a,4,5,5,5a,5b,6-dodecachlorooctahydro-1H-1,3,4-(methanetriyl)cyclobuta[cd]pentalene
related_synonym: 1,2,3,4,5,5,6,7,8,9,10,10-dodecachloropentacyclo[5.3.0.0(2,6).0(3,9).0(4,8)]decane; CG-1283; Dechlorane; Formula=C10Cl12; InChI=1S/C10Cl12/c11-1-2(12)7(17)4(14)3(13,5(1,15)9(7,19)20)6(1,16)10(21,22)8(2,4)18; InChIKey=GVYLCNUFSHDAAW-UHFFFAOYSA-N; SMILES=ClC1(Cl)C2(Cl)C3(Cl)C4(Cl)C(Cl)(Cl)C5(Cl)C3(Cl)C1(Cl)C5(Cl)C24Cl; dodecachlorooctahydro-1,3,4-metheno-2H-cyclobuta[cd]pentalene; perchlorodihomocubane; perchloropentacyclo[5.2.1.0(2,6).0(3,9).0(5,8)]decane; perchloropentacyclodecane
xref: Beilstein:2010845; CAS:2385-85-5; Gmelin:1789502; HMDB:HMDB0059573; KEGG:C14184
xref_mesh: MESH:D008917
xref: PPDB:1294; Patent:US2702305; Patent:US2724730; Reaxys:2010845; Wikipedia:Mirex
G
Abcc6
ATP-binding cassette, sub-family C member 6
decreases expression
ISO
Mirex results in decreased expression of ABCC6 mRNA
CTD
PMID:23153324
NCBI chr 7:45,625,804...45,679,915
Ensembl chr 7:45,616,979...45,679,726
G
Abcg5
ATP binding cassette subfamily G member 5
increases expression
ISO
Mirex results in increased expression of ABCG5 mRNA
CTD
PMID:23153324
NCBI chr17:84,965,602...84,990,439
Ensembl chr17:84,965,662...84,990,439
G
Aqp9
aquaporin 9
decreases expression
ISO
Mirex results in decreased expression of AQP9 mRNA
CTD
PMID:23153324
NCBI chr 9:71,017,941...71,075,170
Ensembl chr 9:71,017,941...71,075,964
G
Ar
androgen receptor
multiple interactions
ISO
[DDT analog co-treated with Hexachlorocyclohexane analog co-treated with Chlorobenzenes co-treated with Mirex co-treated with Polychlorinated Biphenyls co-treated with Chlordan co-treated with Toxaphene co-treated with Hydrocarbons, Chlorinated] inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]
CTD
PMID:21295777
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Atp1b1
ATPase, Na+/K+ transporting, beta 1 polypeptide
decreases expression
ISO
Mirex results in decreased expression of ATP1B1 mRNA
CTD
PMID:23153324
NCBI chr 1:164,264,668...164,285,924
Ensembl chr 1:164,264,678...164,285,924
G
Atp2c1
ATPase, Ca++-sequestering
decreases expression
ISO
Mirex results in decreased expression of ATP2C1 mRNA
CTD
PMID:23153324
NCBI chr 9:105,288,561...105,398,456
Ensembl chr 9:105,280,738...105,404,518
G
Bcat1
branched chain aminotransferase 1, cytosolic
increases expression
ISO
Mirex results in increased expression of BCAT1 mRNA
CTD
PMID:23153324
NCBI chr 6:144,939,561...145,021,883
Ensembl chr 6:144,939,561...145,021,910
G
Ccnb1
cyclin B1
increases expression
ISO
Mirex results in increased expression of CCNB1 mRNA
CTD
PMID:23153324
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
G
Ccnb2
cyclin B2
increases expression
ISO
Mirex results in increased expression of CCNB2 mRNA
CTD
PMID:23153324
NCBI chr 9:70,314,971...70,328,836
Ensembl chr 9:70,314,974...70,328,829
G
Cdkn3
cyclin dependent kinase inhibitor 3
increases expression
ISO
Mirex results in increased expression of CDKN3 mRNA
CTD
PMID:23153324
NCBI chr14:46,997,912...47,008,987
Ensembl chr14:46,997,998...47,009,126
G
Cenpe
centromere protein E
increases expression
ISO
Mirex results in increased expression of CENPE mRNA
CTD
PMID:23153324
NCBI chr 3:134,918,324...134,979,301
Ensembl chr 3:134,918,298...134,979,372
G
Chrna1
cholinergic receptor nicotinic alpha 1 subunit
decreases expression
ISO
Mirex results in decreased expression of CHRNA1 mRNA
CTD
PMID:23153324
NCBI chr 2:73,393,625...73,410,682
Ensembl chr 2:73,393,559...73,410,682
G
Csf3
colony stimulating factor 3 (granulocyte)
increases expression
ISO
Mirex results in increased expression of CSF3 mRNA
CTD
PMID:23153324
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Cyp2b10
cytochrome P450, family 2, subfamily b, polypeptide 10
multiple interactions
EXP
Mirex results in increased expression of and results in increased activity of CYP2B10 protein
CTD
PMID:8722114
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
G
Cyp2b13
cytochrome P450, family 2, subfamily b, polypeptide 13
increases expression
ISO
Mirex results in increased expression of CYP2B2 mRNA; Mirex results in increased expression of CYP2B2 protein
CTD
PMID:1715015
NCBI chr 7:25,760,813...25,795,622
Ensembl chr 7:25,760,922...25,795,622
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression
ISO
Mirex results in decreased expression of CYP2E1 protein
CTD
PMID:3113478
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Ect2
ect2 oncogene
increases expression
ISO
Mirex results in increased expression of ECT2 mRNA
CTD
PMID:23153324
NCBI chr 3:27,151,371...27,207,971
Ensembl chr 3:27,151,371...27,208,027
G
Elovl7
ELOVL fatty acid elongase 7
increases expression
ISO
Mirex results in increased expression of ELOVL7 mRNA
CTD
PMID:23153324
NCBI chr13:108,350,860...108,423,643
Ensembl chr13:108,350,938...108,422,217
G
Ereg
epiregulin
increases expression
ISO
Mirex results in increased expression of EREG mRNA
CTD
PMID:23153324
NCBI chr 5:91,222,476...91,241,508
Ensembl chr 5:91,222,481...91,241,505
G
Esr1
estrogen receptor 1 (alpha)
multiple interactions
ISO
[DDT analog co-treated with Hexachlorocyclohexane analog co-treated with Chlorobenzenes co-treated with Mirex co-treated with Polychlorinated Biphenyls co-treated with Chlordan co-treated with Toxaphene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of ESR1 mRNA
CTD
PMID:21295777
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Hk2
hexokinase 2
increases expression
ISO
Mirex results in increased expression of HK2 mRNA
CTD
PMID:23153324
NCBI chr 6:82,702,004...82,751,437
Ensembl chr 6:82,702,006...82,751,435
G
Kif18b
kinesin family member 18B
increases expression
ISO
Mirex results in increased expression of KIF18B mRNA
CTD
PMID:23153324
NCBI chr11:102,796,344...102,815,960
Ensembl chr11:102,796,355...102,815,950
G
Lmnb1
lamin B1
increases expression
ISO
Mirex results in increased expression of LMNB1 mRNA
CTD
PMID:23153324
NCBI chr18:56,840,885...56,886,496
Ensembl chr18:56,840,885...56,886,496
G
Lrrc1
leucine rich repeat containing 1
increases expression
ISO
Mirex results in increased expression of LRRC1 mRNA
CTD
PMID:23153324
NCBI chr 9:77,338,103...77,453,749
Ensembl chr 9:77,338,105...77,452,152
G
Meox2
mesenchyme homeobox 2
increases expression
ISO
Mirex results in increased expression of MEOX2 mRNA
CTD
PMID:23153324
NCBI chr12:37,158,539...37,229,533
Ensembl chr12:37,158,539...37,229,533
G
Mmd
monocyte to macrophage differentiation-associated
increases expression
ISO
Mirex results in increased expression of MMD mRNA
CTD
PMID:23153324
NCBI chr11:90,078,513...90,169,399
Ensembl chr11:90,140,282...90,169,415
G
Nnt
nicotinamide nucleotide transhydrogenase
decreases expression
ISO
Mirex results in decreased expression of NNT mRNA
CTD
PMID:23153324
NCBI chr13:119,472,063...119,545,793
Ensembl chr13:119,471,984...119,545,533 Ensembl chr13:119,471,984...119,545,533
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
decreases expression
ISO
Mirex results in decreased expression of NR3C1 protein
CTD
PMID:1638671 PMID:1673321
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Nt5dc2
5'-nucleotidase domain containing 2
increases expression
ISO
Mirex results in increased expression of NT5DC2 mRNA
CTD
PMID:23153324
NCBI chr14:30,853,046...30,861,081
Ensembl chr14:30,853,010...30,861,081
G
Odc1
ornithine decarboxylase, structural 1
increases activity
ISO
Mirex results in increased activity of ODC1 protein
CTD
PMID:2283661
NCBI chr12:17,594,906...17,601,503
Ensembl chr12:17,594,795...17,601,506
G
Pttg1
pituitary tumor-transforming gene 1
increases expression
ISO
Mirex results in increased expression of PTTG1 mRNA
CTD
PMID:23153324
NCBI chr11:43,311,097...43,317,417
Ensembl chr11:43,311,077...43,317,078
G
Rfc4
replication factor C (activator 1) 4
increases expression
ISO
Mirex results in increased expression of RFC4 mRNA
CTD
PMID:23153324
NCBI chr16:22,932,698...22,946,480
Ensembl chr16:22,932,693...22,946,487
G
Serpinb2
serine (or cysteine) peptidase inhibitor, clade B, member 2
increases expression
ISO
Mirex results in increased expression of SERPINB2 mRNA
CTD
PMID:23153324
NCBI chr 1:107,439,153...107,453,330
Ensembl chr 1:107,439,153...107,463,208
G
Slc10a1
solute carrier family 10 (sodium/bile acid cotransporter family), member 1
decreases expression
ISO
Mirex results in decreased expression of SLC10A1 mRNA
CTD
PMID:23153324
NCBI chr12:80,999,959...81,015,479
Ensembl chr12:80,999,957...81,015,479
G
Slc16a1
solute carrier family 16 (monocarboxylic acid transporters), member 1
decreases expression
ISO
Mirex results in decreased expression of SLC16A1 mRNA
CTD
PMID:23153324
NCBI chr 3:104,545,980...104,565,778
Ensembl chr 3:104,545,984...104,565,778
G
Slc16a4
solute carrier family 16 (monocarboxylic acid transporters), member 4
decreases expression
ISO
Mirex results in decreased expression of SLC16A4 mRNA
CTD
PMID:23153324
NCBI chr 3:107,198,543...107,219,437
Ensembl chr 3:107,198,546...107,219,431
G
Slc16a7
solute carrier family 16 (monocarboxylic acid transporters), member 7
decreases expression
ISO
Mirex results in decreased expression of SLC16A7 mRNA
CTD
PMID:23153324
NCBI chr10:125,055,139...125,225,455
Ensembl chr10:125,055,139...125,225,334
G
Slc17a3
solute carrier family 17 (sodium phosphate), member 3
decreases expression
ISO
Mirex results in decreased expression of SLC17A3 mRNA
CTD
PMID:23153324
NCBI chr13:24,020,905...24,044,701
Ensembl chr13:24,023,417...24,044,699
G
Slc17a5
solute carrier family 17 (anion/sugar transporter), member 5
decreases expression
ISO
Mirex results in decreased expression of SLC17A5 mRNA
CTD
PMID:23153324
NCBI chr 9:78,443,769...78,495,346
Ensembl chr 9:78,443,770...78,495,323
G
Slc19a2
solute carrier family 19 (thiamine transporter), member 2
decreases expression
ISO
Mirex results in decreased expression of SLC19A2 mRNA
CTD
PMID:23153324
NCBI chr 1:164,076,615...164,092,954
Ensembl chr 1:164,076,615...164,092,954
G
Slc2a2
solute carrier family 2 (facilitated glucose transporter), member 2
decreases expression
ISO
Mirex results in decreased expression of SLC2A2 mRNA
CTD
PMID:23153324
NCBI chr 3:28,752,052...28,782,510
Ensembl chr 3:28,752,052...28,785,508
G
Slc31a2
solute carrier family 31, member 2
decreases expression
ISO
Mirex results in decreased expression of SLC31A2 mRNA
CTD
PMID:23153324
NCBI chr 4:62,198,630...62,216,649
Ensembl chr 4:62,180,799...62,216,648
G
Slc34a2
solute carrier family 34 (sodium phosphate), member 2
decreases expression
ISO
Mirex results in decreased expression of SLC34A2 mRNA
CTD
PMID:23153324
NCBI chr 5:53,206,695...53,229,006
Ensembl chr 5:53,195,423...53,229,006
G
Slc38a1
solute carrier family 38, member 1
increases expression
ISO
Mirex results in increased expression of SLC38A1 mRNA
CTD
PMID:23153324
NCBI chr15:96,469,299...96,541,396
Ensembl chr15:96,469,299...96,540,794
G
Slc4a7
solute carrier family 4, sodium bicarbonate cotransporter, member 7
increases expression
ISO
Mirex results in increased expression of SLC4A7 mRNA
CTD
PMID:23153324
NCBI chr14:7,669,819...7,766,808
Ensembl chr14:7,669,823...7,767,484
G
Slc5a6
solute carrier family 5 (sodium-dependent vitamin transporter), member 6
decreases expression
ISO
Mirex results in decreased expression of SLC5A6 mRNA
CTD
PMID:23153324
NCBI chr 5:31,193,380...31,206,268
Ensembl chr 5:31,193,380...31,206,268
G
Slc7a2
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2
decreases expression
ISO
Mirex results in decreased expression of SLC7A2 mRNA
CTD
PMID:23153324
NCBI chr 8:41,315,404...41,375,107
Ensembl chr 8:41,315,433...41,375,345
G
Slc7a6
solute carrier family 7 (cationic amino acid transporter, y+ system), member 6
decreases expression
ISO
Mirex results in decreased expression of SLC7A6 mRNA
CTD
PMID:23153324
NCBI chr 8:106,894,718...106,925,346
Ensembl chr 8:106,895,489...106,925,338
G
Tat
tyrosine aminotransferase
multiple interactions
ISO
[Mirex co-treated with Corticosterone] results in increased activity of TAT protein
CTD
PMID:2893471
NCBI chr 8:110,712,710...110,726,436
Ensembl chr 8:110,717,069...110,726,435
G
Trip13
thyroid hormone receptor interactor 13
increases expression
ISO
Mirex results in increased expression of TRIP13 mRNA
CTD
PMID:23153324
NCBI chr13:74,060,577...74,085,855
Ensembl chr13:74,059,466...74,085,903
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all